Table 1.
hERα-F | 5′-CCACCAACCAGTGCACCATT-3′ |
hERα-R | 5′-GGTCTTTTCGTATCCCACCTTTC-3′ |
hERβ-F | 5′-AAGAATATCTCTGTGTCAAGGCCATG-3′ |
hERβ-R | 5′-GGCAATCACCCAAACCAAAG-3′ |
hPR-F | 5′-CGCGCTCTACCCTGCACTC-3′ |
hPR-R | 5′-TGAATCCGGCCTCAGGTAGTT-3′ |
hFibulin-1-F | 5′-CCGGATGGCCACTCATCAGA-3′ |
hFibulin-1-R | 5′-CCCATTCAGGTCCTGGCACA-3′ |
hRARα-F | 5′-CCCGGCTTCACCACCCTCACCAT-3′ |
hRARα-R | 5′-AGCCCCGTCTCCGCATCATCCATC-3′ |
hCyclin D1-F | 5′-GTGCTGCGGGCCATGCTGAAGG-3′ |
hCyclin D1-R | 5′-TCGGGCCGGATGGAGTTGTCG-3′ |
hRIP140-F | 5′-GCTGGGCATAATGAAGAGGA-3′ |
hRIP140-R | 5′-CAAAGAGGCCAGTAATGTGCTATC-3′ |
h28S-F | 5′-CGATCCATCATCCGCAATG-3′ |
h28S-R | 5′-AGCCAAGCTCAGCGCAAC-3′ |
F, forward; h, human; R, reverse; RAR, retinoic acid receptor.